ATYR
aTyr Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATYR Filings
Filing Date
Form Description
Form Type
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-06
Form 8-K - Current report
Key Events
2025-11-06 · Key Events
Form 8-K - Current report
2025-10-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-09-15
Form 8-K - Current report
Key Events
2025-09-15 · Key Events
Form 8-K - Current report
2025-08-19
Form EFFECT - Notice of Effectiveness
2025-08-19 ·
Form EFFECT - Notice of Effectiveness
2025-08-13
Form CORRESP - Correspondence
SEC Inquiries
2025-08-13 · SEC Inquiries
Form CORRESP - Correspondence
2025-08-13
Form UPLOAD - SEC-generated letter
SEC Inquiries
2025-08-13 · SEC Inquiries
Form UPLOAD - SEC-generated letter
2025-08-08
Form 8-K/A - Current report: [Amend]
Key Events
2025-08-08 · Key Events
Form 8-K/A - Current report: [Amend]
2025-08-07
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-08-07 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
